The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability

Lucia Morbidelli, Anastasia Pyriochou, Sandra Filippi, Ioannis Vasileiadis, Charis Roussos, Zongmin Zhou, Heleni Loutrari, Johannes Waltenberger, Anne Stoessel, Athanassios Giannis, Marina Ziche, Andreas Papapetropoulos

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)R824-R832
JournalAmerican Journal of Physiology-regulatory Integrative and Comparative Physiology
Volume298
Issue number3
DOIs
Publication statusPublished - Mar 2010

Keywords

  • cGMP
  • vessels
  • sprouting
  • leakage
  • p38

Cite this

Morbidelli, L., Pyriochou, A., Filippi, S., Vasileiadis, I., Roussos, C., Zhou, Z., Loutrari, H., Waltenberger, J., Stoessel, A., Giannis, A., Ziche, M., & Papapetropoulos, A. (2010). The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability. American Journal of Physiology-regulatory Integrative and Comparative Physiology, 298(3), R824-R832. https://doi.org/10.1152/ajpregu.00222.2009